About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
DecisionDx-Melanoma Test Outperforms Existing Methods in Identifying Low-Risk Melanoma Patients
A new study published in Cancer Diagnosis & Prognosis shows that Castle Biosciences' DecisionDx-Melanoma test surpasses both American Joint Committee ...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
DecisionDx-Melanoma Test Outperforms Existing Methods in Identifying Low-Risk Melanoma Patients